Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor βreceptor (PDGFβR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2)

Theodora S. Ross, Olivier A. Bernard, Roland Berger, D. Gary Gilliland

Research output: Contribution to journalArticle

160 Scopus citations


We report the fusion of the Huntingtin interactin protein I (HIP1) gene to the platelet-derived growth factor βreceptor (PDGFβR) gene in a patient with chronic myelomonocytic leukemia (CMML) with a t(5;7)(q33;q11.2) translocation. Southern blot analysis of patient bone marrow cells with a PDGFβR gene probe demonstrated rearrangement of the PDGFβR gene. Anchored polymerase chain reaction using PDGFβR primers identified chimeric transcript containing the HIP1 gene located at 7q11.2 fused to the PDGFβR gene on 5q33. HIP1 is a 116-kD protein recently cloned by yeast two-hybrid screening for proteins that interact with Huntingtin, the mutated protein in Huntington's disease. The consequence of t(5;7)(q33;q11.2) is an HIP1/PDGFβR fusion gene that encodes amino acids 1 to 950 of HIP1 joined in-frame to the transmembrane and tyrosine kinase domains of the PDGFβR. The reciprocal PDGFβR/HIP1 transcript is not expressed. HIP1/PDGFβR is a 180-kD protein when expressed in the murine hematopoietic cell line, Be/F3, and is constitutively tyrosine phosphorylated. Furthermore, HIP1/PDGFβR transforms the Be/F3 cells to interleukin-3-independent growth. These data are consistent with an alternative mechanism for activation of PDGFβR tyrosine kinase activity by fusion with HIP1, leading to transformation of hematopoietic cells, and may implicate Huntingtin or HIP1 in the pathogenesis of hematopoietic malignancies.

Original languageEnglish (US)
Pages (from-to)4419-4426
Number of pages8
Issue number12
StatePublished - Jun 23 1998


ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this